, due mainly to a decrease in the size of the Company’s credit balance accounts during the first quarter of 2019. 1.4 Gains and return on financial instruments The Company’s gains and return on financial

4th quarter of 2018). The proportion of gross profit per sales increased due to control of loss from production, the development of the employee’s skills in the production line and the decrease cost of

amount 29.592 million baht, compared with the same period of 2018, gross profit amount 20.963 million baht, increasing gross profit amount 8.629 million baht or 41.163 percent increase due to Cost of sales

changes in network OPEX ( excluding cost of TOT partnership + 10% YoY, -1.6% QoQ) and SG&A (+7.1% YoY, -2.6% QoQ) . Net profit was reported at Bt7,615mn, decreasing 5.3% YoY due to higher network and

over 20%. In the quarter 1/2019 , the net profit was Baht 0.12 million, compared with the net profit of Baht 8.11 million in quarter 1/2018, decreased by Baht 7.99 million or 98.52% due to the major

the parent on consolidated financial statement. 2) Decimal numbers shown in this management discussion and analysis are likely to be different from the Company’s financial statement due to the rounding

and the three-month period ended March 31, 2019, respectively. The figures represent a period-on-period increase of 87.40% due mainly to an increasing in number of patients as a result of a new building

of Baht 5.47 million or 211.20 % increase due to recording of the interest payable for convertible debenture whereas there is no this transaction in 2018 Summary of the financial status as ended 31

341 mil from q-q, primarily due to business combination consolidated TBSP Public Company Limited (“TBSP”) since April 4, 2018. Excluding TBSP, Company’s core revenues increased by 20.6% or THB 64 mil

Company’s revenue from sales of biodiesel, Edible Oil and by-products in the 1st quarter of 2019 was increased by 0.78 million Baht or 0.19% from the 1st quarter of 2018 due to the increased in quantities